odevixibat (as odevixibat sesquihydrate) 1200 MCG Oral Capsule
- RxCUI
- 2564003
- RxNorm name
- odevixibat (as odevixibat sesquihydrate) 1200 MCG Oral Capsule
- Display name
- odevixibat (as odevixibat sesquihydrate) 1200 MCG Oral Capsule
- Full name
- odevixibat (as odevixibat sesquihydrate) 1200 MCG Oral Capsule
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:48
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| BYLVAY | ODEVIXIBAT | Albireo Pharma, Inc. | 151f1d3e-2bf4-47ce-b1be-a892de3258fa | 2025-12-31 | Warnings, Adverse reactions | 2564003 |
| Bylvay | ODEVIXIBAT | Ipsen Biopharmaceuticals, Inc. | 0935cd31-3251-4a0a-ac23-25ca4be12be9 | 2025-12-29 | Warnings, Adverse reactions | 2564003 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 151f1d3e-2bf4-47ce-b1be-a892de3258fa | odevixibat 1200 MCG Oral Capsule [PSN] · odevixibat 1.2 MG Oral Capsule [SCD] · odevixibat (as odevixibat sesquihydrate) 1200 MCG Oral Capsule [SY] · odevixibat 1200 MCG Oral Capsule [SY] | 4 | 9 | These highlights do not include all the information needed to use BYLVAY safely and effectively. See full prescribing information for BYLVAY. BYLVAY (odevixibat) capsules, for oral use BYLVAY (odevixibat) oral pellets Initial U.S. Approval: 2021 | 20251231 |
| 0935cd31-3251-4a0a-ac23-25ca4be12be9 | odevixibat 1200 MCG Oral Capsule [PSN] · odevixibat 1.2 MG Oral Capsule [SCD] · odevixibat (as odevixibat sesquihydrate) 1200 MCG Oral Capsule [SY] · odevixibat 1200 MCG Oral Capsule [SY] | 4 | 4 | These highlights do not include all the information needed to use BYLVAY safely and effectively. See full prescribing information for BYLVAY. BYLVAY (odevixibat) capsules, for oral use BYLVAY (odevixibat) oral pellets Initial U.S. Approval: 2021 | 20251229 |